%0 Journal Article %K Post-kala-azar dermal leishmaniasis (PKDL) %K Social Stigma %K Efficacy %K Safety %K Elimination %K Treatment %B PLoS neglected tropical diseases %D 2024 %G ENG %N 6 %P 1-15 %R 10.1371/journal.pntd.0012242 %T A phase II, non-comparative randomised trial of two treatments involving liposomal amphotericin B and miltefosine for post-kala-azar dermal leishmaniasis in India and Bangladesh. %U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11189210/pdf/pntd.0012242.pdf %V 18 %1

https://www.ncbi.nlm.nih.gov/pubmed/38900786

%8 06/2024 %9 Article